skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: ACR Appropriateness Criteria on Resectable Rectal Cancer

Journal Article · · International Journal of Radiation Oncology, Biology and Physics
 [1];  [2];  [3];  [4];  [5];  [6];  [7];  [8];  [9]
  1. Department of Radiation Oncology, Wake Forest University, School of Medicine, Winston Salem, NC (United States)
  2. Department of Radiation Oncology, Johns Hopkins Hospital, Baltimore, MD (United States)
  3. Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA (United States)
  4. Department of Radiation Medicine, University of Kentucky Medical Center, Lexington, KY (United States)
  5. Inova Alexandria Cancer Center, Alexandria, VA (United States)
  6. Department of Radiation Oncology, University of Maryland Medical Center, Baltimore, MD (United States)
  7. VA Medical Center, San Diego, CA (United States)
  8. Department of Medical Oncology, Memorial-Sloan Kettering Cancer Center, New York, NY (United States)
  9. Radiation Oncology Department, Emory University School of Medicine, Atlanta, GA (United States)

The American College of Radiology (ACR) Appropriateness Criteria on Resectable Rectal Cancer was updated by the Expert Panel on Radiation Oncology-Rectal/Anal Cancer, based on a literature review completed in 2007.

OSTI ID:
21124148
Journal Information:
International Journal of Radiation Oncology, Biology and Physics, Vol. 70, Issue 5; Other Information: DOI: 10.1016/j.ijrobp.2007.09.029; PII: S0360-3016(07)04256-3; Copyright (c) 2008 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0360-3016
Country of Publication:
United States
Language:
English

Similar Records

ACR Appropriateness Criteria Retreatment of Recurrent Head and Neck Cancer After Prior Definitive Radiation
Journal Article · Mon Aug 01 00:00:00 EDT 2011 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:21124148

ACR Appropriateness Criteria on Induction and Adjuvant Therapy for Stage N2 Non-Small-Cell Lung Cancer: Expert Panel on Radiation Oncology-Lung
Journal Article · Mon Nov 15 00:00:00 EST 2010 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:21124148

A Phase II study of preoperative radiotherapy and concomitant weekly irinotecan in combination with protracted venous infusion 5-fluorouracil, for resectable locally advanced rectal cancer
Journal Article · Fri Sep 01 00:00:00 EDT 2006 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:21124148